CA-CEPTON-TECHNOLOGIES
2.3.2021 14:02:09 CET | Business Wire | Press release
A state-of-the art electronic tolling system that utilizes high-performance lidar sensors from Cepton and a cutting-edge vehicle identification solution from Red Fox ID is expected to be deployed on a major highway turnpike crossing multiple states in the United States, thereby promising fast, highly accurate, barrier-free, real-time tolling to enable smooth traffic flows. This marks the maturing of the deep partnership between Cepton and Red Fox ID in bringing innovative, automated tolling solutions to major customers across North America, EMEA and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005524/en/
Based on an extended collaboration with leading lidar solution provider Cepton, Red Fox ID – a leading designer and developer of vehicle identification and classification solutions - has developed a multi-lane, free flow tolling system called Quantum , which is able to accurately detect, track and classify vehicles of any size or type at highway speeds. Quantum uses Cepton’s Micro Motion Technology (MMT® ) based Sora™-P60 or Sora™-P90 lidar sensors for high-resolution vehicle profiling, to enable integrators and road operators to achieve highly accurate customer billing in real time, with free flow, barrier-free tolling.
For tolls to be charged correctly based on vehicle class, traditional tolling systems often use tollbooths for manual processing or depend on vehicle speed reduction infrastructure to allow for time to capture vehicle information. That can cause congestion, increased emissions and frustration amongst customers. More advanced systems that aim to enable faster tolling, however, are often subject to significant errors, such as missed vehicles or wrong vehicle classification, due to known limitations of the sensors currently being used, such as cameras and weight-based ground sensors. Vehicle classification errors can have significant operating cost consequences for tolling operators while leakage leads to lower revenues. With tollways processing tens of millions of vehicles a year, the cumulative impact of inaccuracies and errors creates significant administrative costs, losses and customer dissatisfaction.
Red Fox ID’s Quantum solution addresses such challenges by adding an extra layer of accuracy to the tolling system by integrating Cepton’s unique lidar technology. A gantry-mounted system using Quantum is therefore able to accurately detect and track vehicles, even as they switch lanes. The lidar-enabled Quantum solution captures and extracts high quality information, such as vehicle velocity, size and class. All of that information is used as input to a separate billing system to compute and apply the appropriate tolling charge. Quantum can also direct camera-based systems on the gantry to capture a vehicle’s front and rear plates in the event that a transponder cannot be detected. Through these innovations, Quantum has demonstrated a vehicle detection accuracy in all traffic conditions of 99.96%, an axle classification accuracy in all traffic conditions of 99.9% and a vehicle length accuracy of +/-5%. This world-class performance is enabled by Cepton’s innovative Sora-P sensor family which has been tested and proven during extended trials, including in various weather and light conditions.
The recently released Sora-P90 lidar features an industry-leading 380 Hz frame rate to deliver 1140 line scans per second, providing high-fidelity profiling of vehicles passing at highway speeds . Powered by Cepton’s patented, rotation-free, frictionless and mirrorless MMT® , the Sora-P90 is rugged, reliable and scalable, making it ideally suited for automated tolling applications. In addition, with its 90° horizontal field of view, the lidar can be set up using one gantry instead of requiring two separate sensors and gantries, making overall deployment more cost effective for tolling system integrators.
With their unparalleled experienced in building innovative tolling solutions, and deep understanding of the industry trend away from ground loop-based tolling systems towards next-generation gantry-based overhead systems powered by advanced sensor technologies, Red Fox ID has been working with Cepton on multiple trials and proof of concept projects across the globe since 2019. This has allowed both partners to expand the application of advanced lidar intelligence for high accuracy tolling on highways and roadways in a growing list of countries, across North America, EMEA and Asia.
Steve Bird, CEO of Red Fox ID, said: “Our industry’s drive for overhead tolling solutions has failed to materialize in the mainstream due, primarily, to a lack of sensors capable of achieving the high levels of accuracy required for a modern tolling product. The technical innovations enabled by Cepton offers us new design options. Improvements in the resolution of the data, the ability to deal with the full range of weather-related conditions, and the development of a sensor with an in-service lifespan suitable for tolling make it possible, for the first time, for us to develop an accurate, overhead free flow system. Our partnership with Cepton will be a game-changer in revolutionizing the tolling market.”
Dr. Jun Pei, CEO of Cepton, added: “It is very clear that lidar’s uses extend far beyond just serving as the ‘eyes’ of autonomous vehicles. Our lidar technology has a huge part to play in making our transport infrastructure smarter, safer, greener and more efficient, as we can see here following Quantum’s highly successful real-world testing. The key to success for toll operators and providers is minimal error and maximum yield, and we are excited to be partnering with Red Fox ID to help our mutual customers achieve this goal with our market-leading lidar technology. We look forward to working with them to expand our partnership worldwide.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .
About Red Fox ID Limited
Red Fox ID is a technology provider, primarily for the global tolling market and also for the broader ITS markets.
A company with over 3 decades of proven experience in the delivery of innovative, forward looking and industry leading solutions for the world of all weather, multi-lane, free-flow automatic vehicle detection and classification (AVDC). System integrators, toll authorities and road operators select Red Fox ID for their experience in advance sensor integration and expertise in road side tolling systems, from the software to the road side Red Fox ID has domain experts that ensure timely delivery of the industries most accurate AVDC system.
For more information visit www.redfoxid.co.uk or contact us at sales@redfoxid.co.uk or call +44 7866845819.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005524/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the
Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 04:00:00 CEST | Press release
Milestone-based government program supports multiple fusion approaches toward power demonstration and commercialization Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated ove
Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]31.8.2026 23:35:00 CEST | Press release
ITC Infotech Board approves proposed acquisition of 22.1% promoter stake and a Scheme of Amalgamation of the two companies ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will syner
Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule31.8.2026 21:07:00 CEST | Press release
Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announced today that its revenue grew 42.9% to US$230.7 million and net profit grew 79.6% to $25.5 million for the six months ending June 30, 2026. Angel’s business in Europe and North America crossed into profitability ahead of plan while the business in Chinese mainland delivered market share gains well above expectations. Doctors and staff in every region report that they are increasingly selecting Angel’s solutions after experiencing more predictable outcomes, especially on complex cases, and embracing the positive culture of the company. Dr. Mark Holt D.D.S., M.S. of Holt Orthodontics in Northern California, states: “We treat over half of our patients with clear aligners and our experience with Angel’s treatment plans and clear aligners has been tremendous.” “Our main focus is to provide great service to and being a rock-solid partner for our cu
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines31.8.2026 21:00:00 CEST | Press release
Agreement advances patient access and strengthens BeOne's long-term commitment to U.S. innovation and manufacturing BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional res
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
